Jeanna Park1, Nuriya Robinson2, Ursula Wessels3, James Turner3, Stacie Geller4. 1. Department of Obstetrics and Gynecology, University of Illinois, Chicago, USA. Electronic address: jeanna.park@gmail.com. 2. Department of Obstetrics and Gynecology, University of Illinois, Chicago, USA. 3. Department of Obstetrics and Gynecology, Lower Umfolozi District War Memorial Hospital, Empangeni, South Africa. 4. Department of Obstetrics and Gynecology, University of Illinois, Chicago, USA; Department of Obstetrics and Gynecology, Center for Research on Women and Gender, Chicago, USA.
Abstract
OBJECTIVE: To determine the success rate of medical abortion when a progestin-based contraceptive-either an etonogestrel implant or depot medroxyprogesterone acetate (DMPA) injection-is given on the same day as mifepristone for medical abortion. METHODS: In a retrospective chart review, data were assessed for women aged 15-49years who underwent medical abortion (≤63days of pregnancy) at two hospitals in KwaZulu Natal, South Africa, between August 2013 and July 2014. The women were given oral mifepristone (200mg) and buccal misoprostol (800μg), and received an etonogestrel implant or DMPA injection on the same day as mifepristone. The primary outcome was the success rate of medical abortion. Comparative data were obtained through a PubMed search. RESULTS: A total of 89 women were included. Complete termination was achieved in 87 (98%, 95% confidence interval 95%-100%) women. This success rate is similar to that reported in a previous systematic review of the rate of medical abortion success without progestin contraceptive administration (94.8%). CONCLUSIONS: Administration of a progestin-based contraceptive such as an etonogestrel implant or DMPA injection on the same day as mifepristone for medical abortion did not alter the success rates. Published by Elsevier Ireland Ltd.
OBJECTIVE: To determine the success rate of medical abortion when a progestin-based contraceptive-either an etonogestrel implant or depot medroxyprogesterone acetate (DMPA) injection-is given on the same day as mifepristone for medical abortion. METHODS: In a retrospective chart review, data were assessed for women aged 15-49years who underwent medical abortion (≤63days of pregnancy) at two hospitals in KwaZulu Natal, South Africa, between August 2013 and July 2014. The women were given oral mifepristone (200mg) and buccal misoprostol (800μg), and received an etonogestrel implant or DMPA injection on the same day as mifepristone. The primary outcome was the success rate of medical abortion. Comparative data were obtained through a PubMed search. RESULTS: A total of 89 women were included. Complete termination was achieved in 87 (98%, 95% confidence interval 95%-100%) women. This success rate is similar to that reported in a previous systematic review of the rate of medical abortion success without progestin contraceptive administration (94.8%). CONCLUSIONS: Administration of a progestin-based contraceptive such as an etonogestrel implant or DMPA injection on the same day as mifepristone for medical abortion did not alter the success rates. Published by Elsevier Ireland Ltd.
Entities:
Keywords:
Depot medroxyprogesterone acetate; Etonogestrel; Medical abortion
Authors: Mary Kawonga; Kelly Blanchard; Diane Cooper; Lee Cullingworth; Kim Dickson; Teresa Harrison; Claire von Mollendorf; Beverly Winikoff Journal: J Fam Plann Reprod Health Care Date: 2008-07
Authors: Lisa K Perriera; Matthew F Reeves; Beatrice A Chen; Heather L Hohmann; Jennifer Hayes; Mitchell D Creinin Journal: Contraception Date: 2009-09-30 Impact factor: 3.375
Authors: Corinne H Rocca; Suzan Goodman; Daniel Grossman; Kara Cadwallader; Kirsten M J Thompson; Elizabeth Talmont; J Joseph Speidel; Cynthia C Harper Journal: Am J Obstet Gynecol Date: 2017-10-03 Impact factor: 8.661